the business of preventing infectious diseases for workplace health and productivity. find us in Broadway theaters, professional sports, retail, & beyond
ASHRAE approves groundbreaking Standard to safeguard indoor spaces from disease transmission. The new ASHRAE Standard 241- Control of Infectious Aerosols is a major step forward in reducing the risk of infectious disease spread in buildings. https://t.co/Jkd918vOF6.
#MyASHRAE
Emerging threat from filovirus highlights need to incentivize innovation of antiviral treatments and vaccine
@WHO@statnews@HelenBranswell
https://t.co/xOMlCnbyla
Flu & COVID combo test is now available for general public to order online.
$99 per battery-powered, disposable, easy-bake-oven style test that runs in 30 min at home.
@LuciraHealth @US_FDA
https://t.co/OZPGj20iOe
Tell me if I need to bring COVID tests to #ISPORAnnual.
All those health economists could make fancier rapid molecular tests cost-effective. Bring lots of swabs & we can hack together batches of pools. Need PhD student to run the Value of Information analysis.
@InfectiousEcon
“A negative result may not actually be a negative result,” said Anne Wyllie, a microbiologist at the Yale School of Public Health and an author of the new study. “People should not ignore high risk exposures. They should not ignore symptoms.” https://t.co/TJy6k8rN5Q
Rapid Covid tests — both Abbott BinaxNOW and Quidel QuickVue — aren’t catching people during their first couple days of infection, a new study shows. https://t.co/Tg1cCwjYtI
Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older. https://t.co/iOqsxXV1fj
Credit to the pioneer COVID Safety Manager Pamela Remler and #InfectiousEconomics Theatrical Liaison Charlene Speyerer for translating scientific evidence into practical theater operations.
@mattross42@passoverbway
The first Broadway play to open after 18 months dark has all eyes watching. It’s been a privilege to advise/train producers, creatives, cast, & crew on COVID epidemiology, prevention, & testing.
@InfectiousEcon@passoverbway@mattross42@Jujamcyn@washingtonpost @petermarksdrama
The Broadway cast of Pass Over @passoverbway played my board game at rehearsal today!
It’s fun playing out scenarios of theater outcomes with daily PCR testing, an action plan for response to positive case, & when/where/why minimal rapid antigen testing.
#infectiouseconomics
Here is my perspective on schools this fall. Race and income inequities, both health and economic burden, are made worse with remote learning. Cost-effective, pooled, routine #COVID__19 testing can be part of the solution — focus on teachers. @USATODAY
https://t.co/OUXXvSV8r7
USEFUL TOOL FOR STATES: https://t.co/2FHIDyjdgZ ranks industries by contribution to local economy & #COVID19 risk. Can inform targeted testing of workers with no symptoms for early action, efficiently protecting health & economic vulnerabilities.
@MaritaZim@IDMod_org@BillGates
It’s hard to chose one best #COVID19 pandemic outcome metric to signal the speed to open up America. A poet once described this type of uncertainty
“I ask the traffic lights
if it'll be alright
They say,
‘I don't know’.”
@taylorswift13#TaylorSwiftCityOfLover
We now have enough #SARSCoV2 genomic data from different states to make some broad conclusions about how the #COVID19 epidemic has unfolded in the US. 1/14